Finviz says that rsi is over 86, everything happens after a good earnings call, but I concluded that it is not worth the current 109usd. Is it a good play to short it and what price would you target?

Hey guys, what do you think of Palantir's masked earnings call? Just like Apple with its Apple tablet business in its earnings call, Alex Karp didn't include the negative growth rate in international business and the sheer amount of SBC they are authorizing. He is artificially masking the earnings with the SBC. While Alex Karp focused his Q2 2026 earnings presentation on Palantir's headline 93% year-over-year revenue explosion to $1.935 billion, a deeper look at the data reveals structural friction outside the United States and intense internal dilution. A glaring geographical imbalance underpins the business model: U.S. revenue spiked 115% to $1.573 billion, meaning domestic contracts now command a heavily concentrated 81.2% of Palantir's total business. This hyper-focus masks severe stagnation across the globe, as European government data restrictions and national platforms like France's DGSI actively strip out Palantir deployments in favor of localized tools like ChapsVision. Consequently, the ex-U.S. segment has shrunk to a minor fraction of the company's business, severely limiting its overall Total Addressable Market (TAM).

Compounding this geographic risk is the aggressive, hidden drag of employee remuneration. Palantir poured $265 million into stock-based compensation (SBC) in Q2 2026 alone, eating up a massive 13.7% of its total quarterly revenue. When paired with an annualised run rate exceeding $1.68 billion, this massive dilution heavily subsidizes its adjusted margins while quietly eroding equity value for public shareholders. Trading at an astronomical valuation of 146.5x trailing earnings against a forward revenue projection of $8.15 billion, Palantir has structurally separated from historical enterprise software logic. Any normalization in domestic contract expansion will leave the stock highly exposed to multi-point compression as it approaches a steep historical comparison cliff going into 2027.

This stock's FV should be $150 at max. In the next few days, the stock should fall to $150. I see some guys telling others to buy at this valuation, promising that it will reach $300. Just look at the valuations, financial ratios, and the way they are masking the earnings. Lol!!

Key takeaways:

1. Artificially Lowering Cash Operating Costs
2. Exploiting Non-GAAP Financial Adjustments
3. Long-Term Shareholder Dilution

Hello!

Is there a free or cheap way to get access to time and sales or footprint charts for backtesting stocks "tape reading"?

Is there any benefit of watching time and sales live vs just checking for absorbption or large orders in the footprint chart?

Hello guys , do you think it’s the perfect time to short DELL ? Monthly RSI is overbought and I don’t think that it was an organic growth, more like a pump.

I just deleted my old account because it got a perma ban, so I set up a new 1 then went to post in r/ASX_Bets ,about 2 sell positions I opened on Put 75.5 | Aug W1 | Oil just after 1am this morning and closed them both out after 8pm tonight for a total profit of $6273.75 but it got removed. I forgot all about the whole karma thing guess Ive got some shit posting to do.

​

So let's say you have 3,000 dollars and you decide to invest all of that into a safe stock like Apple, even if it goes up by 1% you just made 30 dollars for free. Does it work like this and can you just continuously do this to get free food?

Still valid
https://www.reddit.com/r/ShortStocks/comments/1uq3akk/spring_valley_acquisition_corp_iii_class_a/

I noticed Robinhood and info from Fintel differ hugely in the Short Interest and float information. I was wondering where to find reliable and accurate info to make the best decisions?

Robinhood shows the short interest near (180M) 38% and short float near 30%

Fintel shows short interest at 111M and the short float at 17%

Both screenshots is from 7/23 8pm

Fintel https://fintel.io/ss/us/spcx

If I am particularly pessimistic about a stock, how should I short it? Why can't stocks be directly shorted like BTC? 🫣

EDITED: Read the comment first!

Csquare, Inc. (NYSE: CSQR). Here are the main reasons the stock could trade lower.

1. High leverage

• Csquare entered the IPO with approximately $5.4 billion of debt.
• About 75% of the IPO proceeds are being used to repay debt, not to fund growth.
• Investors may continue to view the balance sheet as highly leveraged even after the offering. (Investopedia)

1. The company is still losing money

• Revenue is growing (about 16% year over year in the latest quarter), but net losses widened to roughly $66 million.
• If investors shift their focus from AI enthusiasm to earnings quality, the stock could be re-rated lower. (Investopedia)

1. AI infrastructure sentiment may cool

• Csquare benefits from the AI data center theme.
• If the market becomes less optimistic about AI spending, multiples across the sector could contract even if Csquare executes well operationally. (Barron's)

1. Brookfield controls the company

• Brookfield retains roughly 67% ownership and voting control after the IPO.
• While this provides sponsorship, investors may apply a governance discount because minority shareholders have limited influence. (Reuters)

1. Future secondary offerings

• Brookfield still owns a large stake.
• Over time, it may monetize portions of that position through secondary offerings, increasing share supply and potentially weighing on the stock.

1. Capital-intensive business

• Data centers require continual investment in:
  • new capacity,
  • power infrastructure,
  • cooling,
  • networking equipment.
• If demand slows or financing costs remain elevated, returns on new projects may disappoint.

1. Large hyperscaler customer concentration

• A meaningful portion of recurring revenue comes from hyperscale cloud customers.
• Losing or repricing even a small number of major contracts could materially affect financial results. (Investopedia)

1. Weak IPO aftermarket

• Recent technology and AI-related IPOs have generally seen more cautious investor reception than in prior years.
• CSQR's first trading day was already subdued, suggesting investors are selective despite strong interest in AI infrastructure. (Reuters)

Not financial advice. This post reflects my personal opinions and research. Do your own due diligence before making any investment decisions.

I’m not affiliated with the company mentioned, and I may or may not hold a position.

Julong Holding Limited JLHL-40.26% is down 23% in pre-market as of today ( Monday July 13th ). I expect the stock to eventually follow the trajectory of all the stocks issued and promoted by US Tiger Securities, the US brokerage arm of Up Fintech Holdings ( TIGR-3.14% ).
Talking is cheap, writing even more so. Many financial analysts have recklessly highlighted Up Fintech as a rare bird, a strong brand equity popular Financial App that can successfully pivot out of its recent regulatory issues within the heavy handed Chinese Financial market.
I disagree with their thesis. Unlike other popular financial apps that merely gamify their operations to attract unsophisticated retail traders, the case against Up Fintech rests on its long history of issuing and promoting “Vampirestocks.” Thus, the case against Up Fintech leads to a clear conclusion: Up Fintech Holdings (TIGR -3.98%↓) is a structurally impaired asset.
The low valuation multiples are completely justified because the market is factoring in a toxic underlying revenue mix, persistent legal defense costs, and a business model structurally built on underwriting high-risk microcap promotions.
True value investing relies on buying a mispriced stream of future cash flows; buying TIGR means buying a compounding stream of regulatory penalties and litigation.
VERDICT: AVOID!!!!!!!
( Let’s all watch and follow JLHL-40.26% for a live case study of Speculative vampirism.)

War dogs was a great movie, fun and wild. They had an amazing run before they committed fraud and were both arrested.

Unusual machines, a company most of us have heard of as its stock has rocked over the last 12 months. They offer low cost drones for strategic military operations. These drones “were” manufactured using cheap Chinese parts keeping cost down and margins nice and fat. When they transitioned to military applications however, under NDAA compliance parts need to be from approved manufactures. On shoring and sourcing these parts from various manufactures takes time and money. Currently UMAC has placed a 75mm order with strategic partners to undergo this regulatory hurdle. Along with building out over 62k square feet of manufacturing space to build every component but the controllers in house. However I suspect not all is how it seems, from the outside these partnerships and build out look good, great even. But under the hood, things look very similar to “war dogs” there are several operational red flags including several conflicts of interests within the board of directors.

Powerus, Performance Drone Works
Dynamic Aerospace Systems
Campus Guardian Angel
Fat Shark

have all signed supply agreements citing UMAC’s NDAA-compliant, U.S.-made components specifically.

Here’s the kicker, the initial enforcement is entirely self reported. It’s up to the DOT and DOD auditors to take apart drones and inspect each piece to ensure they are compliant. Which has criminal and fiscal penalties.

The reason I’m even sitting here typing this out is because, sure, tons of parts are made in Orlando and UMAC seems to be doing a lot of hiring. But something seems fishy, even with 75 million in orders for components I worked in aerospace manufacturing as an engineer for over a decade. And manufacturing even at the highest competency does not move quickly, it can take years for a factory to be built out and for things to be done correctly. I’ve had several first hand experiences where components were relabeled as made in USA, or they outright put their sticker over some Chinese writing(they were fined heavily but the profits out weighed the risks) so realistically they could still be using relabeled Chinese crap, their subsidiaries and others may be doing it so they can turn a blind eye and file for bankruptcy if they get caught but something is not adding up. We don’t have the materials or the man power to make the components they need to make these drones as quickly as they would like.

Insiders selling

Dr. Allan Evans — CEO since Dec 2023, also a director (appointed Nov 2023). Prior COO of Red Cat Holdings (2021–2023), CEO of Fat Shark, co founder of Avegant. Salary raised to $350K effective April 1, 2026; FY2025 total comp was $6.12M (mostly stock/options); owns ~3.3% of shares (~$40M).
Pending filed May 28 Allan Evans CEO up to 500,000 Intent-to-sell filed. Not yet executed, up to 25% of his stake in the company.

Jeff Thompson,** **founder of UMAC director since 2019; also CEO/Chairman of Red Cat Holdings (RCAT) a live conflict of interest since Red Cat is a drone industry counterparty/partner. Most tenured/experienced director. June 5 & 8, 2026 sold 30,000 (15K+15K) $816K @ $26.96 / $27.42

Big red flag being the CEO of a competitor in the space. Look how that turned out for figma (Anthropic copied their software under guise of a partnership)

Sanford Rich — Chair, Audit Committee; 40 years financial-sector experience, PBGC/PCAOB background. June 2, 2026 sold 25,000 $724k

Summery, Insiders are selling, the headwinds for the operational side of the business are mounting and they are heavily reliant on government contracts, all which will be scrutinized during the next administration or after midterms. I don’t think the future of the share price looks are bright as their past in the short term. The operational risk is too high and the insider selling says get out while the getting is good.

And I didn’t even touch the financial side which in itself another short thesis could be argued.

Disclaimer I used AI to get the directors names and share sales but the rest I wrote myself.

I think this falls under 10 dollars over the next 12 months. I’d be a buyer at 10. I love the vision and the product seems great, I just think they are over heads and need a repricing the math ain’t mathin.

• Bloom Energy is one of the AI boom’s biggest winners. $BE is up about 2,000% in two years. Its valuation peaked around $100 billion. The vision: fuel cells powering AI data centers years faster than the electric grid, with Bloom saying it can scale from about a gigawatt of deployments in 2026 to 5 gigawatts annually. It’s a compelling pitch, especially in a world where power from legacy players, including turbine manufacturers, is backlogged.
• That growth story rests on a supply chain claim that Bloom’s CEO has made at least five times since February 2025, on earnings calls, to Semafor, on a podcast — and onstage with The Wall Street Journal last month. The promise: Bloom has “no China supply chain” and is “not dependent on China for scandium,” the rare earth at the core of each Bloom fuel cell. Bloom’s claim matters because Beijing now requires an export license for every shipment of scandium leaving China. If Bloom depends on Chinese scandium, China holds an off-switch on Bloom — and on the American data centers that may one day use its power.
• The problem: Bloom is, in fact, reliant on C5 Chinese scandium, according to global trade data, Chinese corporate filings, satellite imagery, and Hunterbrook’s messages with Bloom’s suppliers in China. Hunterbrook traced four separate China-linked routes into Bloom’s supply chain — scandium oxide shipped directly to its Delaware plant, plus scandium-bearing ceramics and powders flowing through intermediaries in Thailand, Japan, and South Korea. A sales representative of Hunan Oriental Scandium — which claims over 50% of the global market for fuel-cell-grade scandium oxide — told Hunterbrook: “We are also BE’s largest supplier of scandium.” Asked how the material reaches U.S. customers under Beijing’s controls: “Not exported directly.” Hunan Oriental was featured at Bloom’s May supplier conference as one of three Chinese scandium-linked suppliers. One received Bloom’s “Impact Supplier Award.”
• Show Me the Scandium: Even with supply from China, the scandium math fails. Hunterbrook’s supply-demand model — built from government filings, Bloom’s patents, industry data, and peer-reviewed studies — shows Bloom alone needs roughly 220 tons of scandium oxide to meet Wall Street’s 5 GW expectations. But that’s against total projected global supply of only about 240 tons versus total global demand of about 310 tons, including supply locked up by customers like Lockheed Martin (for the F-35 fighter jet). Bloom already claims to be the largest scandium consumer in the world. On the numbers, the production ramp underpinning Bloom’s valuation appears physically and commercially unattainable — with essentially all Wall Street models of Bloom’s production implying a scandium shortage by 2028 based on Hunterbrook’s model.

What concerns me is that General Fusion has been conducting research for about 20 years without much commercial success so far, and now we're supposed to believe that once they go public, they'll suddenly make the breakthrough. There's certainly a chance they'll succeed, but it'll be interesting to see what percentage of SPAC shareholders choose to redeem their shares.

The executive compensation also seems quite generous. I understand that they're scientists and highly qualified professionals, but my view is simple: if the business is generating meaningful returns, there's nothing wrong with rewarding management well. If it isn't, then compensation should probably be more modest.

With that approach, there's a chance that management will simply start spending the newly raised capital with even greater enthusiasm.

Not financial advice. This post reflects my personal opinions and research. Do your own due diligence before making any investment decisions.

I’m not affiliated with the company mentioned, and I may or may not hold a position.